Activating mutations in the receptor tyrosine kinase ALK and loss of function mutations or deletions of genes important for chromatin remodeling, including ATRX, ARID1A, and ARID1B, are observed in high-risk neuroblastoma [2]. The gene discussed is ALK; the disease is neuroblastoma.